Curaleaf HoldingsTSX:CURA -9.08%76 Days Inventory is 127.78 as of Mar. 2026, which is 49% below its 10-year median of 249.65. GuruFocus rates TSX:CURA with a GF Score™ of 76/100 and a GF Value™ of C$11.39 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 919 Drug Manufacturers companies, Curaleaf Holdings ranks better than 65.18% on this metric.
The historical rank and industry rank for Curaleaf Holdings's Days Inventory or its related term are showing as below:
TSX:CURA'
s Days Inventory Range Over the Past 10 Years
Min: 110.59 Med: 249.65 Max: 1384.92
Current: 130.1
During the past 12 years, Curaleaf Holdings's highest Days Inventory was 1384.92. The lowest was 110.59. And the median was 249.65.
TSX:CURA's Days Inventory is ranked better than 65.18% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs TSX:CURA: 130.10
Curaleaf Holdings's Days Inventory
declined
from Mar. 2025 (133.05) to Mar. 2026 (127.78).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Curaleaf Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Curaleaf Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.72.
Curaleaf Holdings (TSX:CURA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Curaleaf Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Curaleaf Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Curaleaf Holdings Days Inventory Related Terms
Curaleaf Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Curaleaf Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaleaf Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Curaleaf Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curaleaf Holdings (TSX:CURA) has a Days Inventory of 127.78 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Curaleaf Holdings and its competitors. This is 49% below median its historical median of 249.65. Over the past decade, Curaleaf Holdings' Days Inventory has ranged from 110.59 to 1,384.92. According to the industry distribution chart, Curaleaf Holdings ranks #320 out of 919 companies in the Drug Manufacturers industry, placing it in the top 34.8%.
Is Curaleaf Holdings' Days Inventory too high?
Curaleaf Holdings' current Days Inventory of 127.78 is 49% below median its 10-year median of 249.65. Over the past 10 years, this metric has ranged from a low of 110.59 to a high of 1,384.92. The Drug Manufacturers industry median Days Inventory is 164.48. Curaleaf Holdings' value of 127.78 is 22.3% below this industry median. Based on the distribution chart, Curaleaf Holdings ranks #320 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Curaleaf Holdings has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #320 out of 919 companies for Days Inventory. This puts Curaleaf Holdings in the upper half of its industry. The industry median Days Inventory is 164.48. Curaleaf Holdings' value of 127.78 is 22.3% below this benchmark. Historically, Curaleaf Holdings' own Days Inventory has ranged from 110.59 to 1,384.92 over the past decade. While the company's 10-year median is 249.65 vs. the industry median of 164.48, Curaleaf Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curaleaf Holdings's current Days Inventory of 127.78 is 22.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Curaleaf Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curaleaf Holdings's current Days Inventory is 127.78, which is 49% below median its own 10-year median of 249.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (TSX:CURA) is currently considered Modestly Overvalued. The stock's GF Value™ is C$11.39, compared to a current price of C$13.32 — trading 16.9% above its estimated fair value. The current Days Inventory is 127.78, which is 49% below median its 10-year median of 249.65 and 22.3% below the Drug Manufacturers industry median of 164.48. Curaleaf Holdings' overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Curaleaf Holdings (TSX:CURA), the current Days Inventory is 127.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curaleaf Holdings (TSX:CURA) Overvalued in 2026?
Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued.
The current stock price of C$13.32 is trading 16.9% above its estimated GF Value™ of C$11.39.
GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.
Key valuation signals for TSX:CURA:
Days Inventory: 127.78 (49% below median its 10-year median of 249.65)
GF Value™: C$11.39 vs. price of C$13.32 (16.9% above fair value)
Industry Position: 22.3% below the Drug Manufacturers median (#320 of 919)
No single metric tells the full story. See the TSX:CURA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
76GF Score
Get the complete analysis for TSX:CURA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:CURA has been successfully added to your 
